#ExistRefRangeSet>
Reference Interval:
#ExistRefRangeTable> | Test Number
| Components
| Reference Interval
| | | Chromium, Urine - per volume
| 0.0-5.0 µg/L
| | | Chromium, Urine - per 24h
| 0.0-6.0 µg/d
| | | Chromium, urine - ratio to CRT
| No reference interval (µg/g crt)
| | 0020473 | Creatinine, 24-Hour Urine
| | Age
| Male
| Female
| | 3-8 years
| 140-700 mg/d
| 140-700 mg/d
| | 9-12 years
| 300-1300 mg/d
| 300-1300 mg/d
| | 13-17 years
| 500-2300 mg/d
| 400-1600 mg/d
| | 18-50 years
| 1000-2500 mg/d
| 700-1600 mg/d
| | 51-80 years
| 800-2100 mg/d
| 500-1400 mg/d
| | 81 years and older
| 600-2000 mg/d
| 400-1300 mg/d
|
|
*ExistRefRangeTable>
|
*ExistRefRangeSet>
#ExistInterpDataSet>
| Interpretive Data: |
#ExistInterpData>Chromium urine levels can be used to monitor short term exposure. The form of chromium greatly influences distribution. Trivalent chromium resides in the plasma and is usually not of clinical importance. Hexavalent chromium is considered highly toxic. Symptoms associated with chromium toxicity vary based upon route of exposure and dose and may include dermatitis, impairment of pulmonary function, gastroenteritis, hepatic necrosis, bleeding, and acute tubular necrosis.
*ExistInterpData>
|
*ExistInterpDataSet>
#ExistCPT>
| CPT Code(s): |
82495
|
*ExistCPT>
#ExistCrossReferences>
Cross References: |
Cr (Chromium, Urine), CRU (Chromium, Urine) |
*ExistCrossReferences>
|